Geode Capital Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $283K | Sell |
|
|||||
|
2024
Q3 | $1M | Sell |
|
|||||
|
2024
Q2 | $723K | Sell |
|
|||||
|
2024
Q1 | $11M | Buy |
|
|||||
|
2023
Q4 | $12.4M | Buy |
|
|||||
|
2023
Q3 | $8.41M | Buy |
|
|||||
|
2023
Q2 | $10.3M | Buy |
|
|||||
|
2023
Q1 | $3.09M | Buy |
|
|||||
|
2022
Q4 | $1.66M | Buy |
|
|||||
|
2022
Q3 | $2.23M | Buy |
|
|||||
|
2022
Q2 | $1.6M | Sell |
|
|||||
|
2022
Q1 | $5.98M | Buy |
|
|||||
|
2021
Q4 | $7.04M | Buy |
|
|||||
|
2021
Q3 | $6.58M | Sell |
|
|||||
|
2021
Q2 | $10.5M | Buy |
|
|||||
|
2021
Q1 | $7.81M | Buy |
|
|||||
|
2020
Q4 | $4.68M | Buy |
|
|||||
|
2020
Q3 | $4.46M | Buy |
|
|||||
|
2020
Q2 | $2.94M | Buy |
|
|||||
|
2020
Q1 | $2.31M | Buy |
|
|||||
|
2019
Q4 | $1.51M | Buy |
|
|||||
|
2019
Q3 | $1.02M | Buy |
|
|||||
|
2019
Q2 | $2.75M | Buy |
|
|||||
|
2019
Q1 | $2.53M | Buy |
|
|||||
|
2018
Q4 | $1.33M | Buy |
|
|||||
|
2018
Q3 | $3.45M | Buy |
|
|||||
|
2018
Q2 | $1.91M | Buy |
|
|||||
|
2018
Q1 | $626K | Hold |
|
|||||
|
2017
Q4 | $1.34M | Buy |
|
|||||
|
2017
Q3 | $616K | Buy |
|
|||||
|
2017
Q2 | $74K | Sell |
|
|||||
|
2017
Q1 | $99K | Buy |
|
|||||
|
2016
Q4 | $56K | Buy |
|
|||||
|
2016
Q3 | $101K | Buy |
|
|||||
|
2016
Q2 | $70K | Buy |
|
|||||
|
2016
Q1 | $279 | Sell |
|
|||||
|
2015
Q4 | $397K | Buy |
|
|||||
|
2015
Q3 | $315K | Buy |
|
|||||
|
2015
Q2 | $421K | Buy |
|
|||||
|
2015
Q1 | $189K | Buy |
|